Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Fabry Disease
Related studies linked through entity extraction aliases.
Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE1
Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy
- Status
- UNKNOWN
- Phase
- N/A
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
- Status
- COMPLETED
- Phase
- NA
Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease
- Status
- WITHDRAWN
- Phase
- PHASE3
Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy
- Status
- COMPLETED
- Phase
- N/A
Fabry Disease in Cerebrovascular Disease
- Status
- UNKNOWN
- Phase
- N/A
Study of the Prevalence of Fabry Disease in French Dialysis Patients
- Status
- UNKNOWN
- Phase
- N/A
Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
- Status
- COMPLETED
- Phase
- PHASE3
Lipidomics and Functional Analyses of Platelets in Fabry Disease
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE3
Screening for Fabry Disease in a Pediatric Population at Risk
- Status
- COMPLETED
- Phase
- N/A
Investigating Lysosomal Storage Diseases in Minority Groups
- Status
- UNKNOWN
- Phase
- N/A
Paricalcitol in Fabry Disease
- Status
- COMPLETED
- Phase
- NA
A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1